We describe a comprehensive protocol for the preparation of multifunctional Dna nanostructures termed nanoflowers (nFs), which are self-assembled from long Dna building blocks generated via rolling-circle replication (rcr) of a designed template. nF assembly is driven by liquid crystallization and dense packaging of building blocks, which eliminates the need for conventional Watson-crick base pairing. as a result of dense Dna packaging, nFs are resistant to nuclease degradation, denaturation or dissociation at extremely low concentrations. By manually changing the template sequence, many different functional moieties including aptamers, bioimaging agents and drug-loading sites could be easily integrated into nF particles, making nFs ideal candidates for a variety of applications in biomedicine. In this protocol, the preparation of multifunctional Dna nFs with highly tunable sizes is described for applications in cell targeting, intracellular imaging and drug delivery. preparation and characterization of functional Dna nFs takes ~5 d; the following biomedical applications take ~10 d.
IntroDuctIon
Advances in nanotechnology have been accompanied by an increasing demand for nanotools that can be applied to noninvasive early diagnosis and targeted therapy. In the past few years, many different materials have been proposed as powerful biomedical tools for use in disease diagnosis and therapy. Among them are exogenous nanomaterials such as organic or inorganic nanoparticles [1] [2] [3] [4] [5] , hydrogels 6, 7 , polymers [8] [9] [10] , liposomes 11 and micelles 12, 13 , which have been shown to possess outstanding features such as resistance to enzymolysis, functional surface modification and excellent optical properties. However, in spite of their unique properties, most of these nanomaterials are challenged by obvious cytotoxicity, structural instability, nonspecificity and sophisticated preparation processes, which largely limit their clinical applications. In addition, when considering their range of applications, nanotools that depend on these materials may become inflexible by the different modification methods needed for new platform construction and covalent bond formation.
Compared with these exogenous materials, DNA is naturally water-soluble and biocompatible. This means that it can be used as a building block to construct various DNA nanostructures 14, 15 with built-in functionalities for biomedical and biotechnological applications 16, 17 . In addition, other advantages such as sequence programmability and automated controllable synthesis also make DNA nanostructures more suitable biomedical nanotools over their exogenous counterparts. Numerous studies have reported on the remarkable potential of DNA nanostructures; representative examples include DNA tetrahedron [18] [19] [20] , DNA dendrimer 21, 22 , DNA origami 14, 17 and hybridization chain reaction-based DNA polymers 23, 24 . Conventional approaches to DNA nanostructure construction typically rely on Watson-Crick base pairing between short DNA building blocks 25 . However, when applied in complicated physiological environments, approaches based on hydrogen bonding and base stacking were proven to have some intrinsic drawbacks. First, to assemble relatively large and sophisticated nanostructures for efficient biological applications, myriad different DNA strands with complicated sequences need to be manually designed. Sometimes even software engineering is needed 26, 27 , making construction a cumbersome process. Second, preparation of DNA nanostructures usually means bulky synthesis of DNA strands, which is an expensive and time-consuming process. Third, DNA hybridization-generated nicks in the DNA backbone typically serve as potential cleavage sites for many exonucleases, which can decrease the biostability of traditional DNA nanostructures 28, 29 . Fourth, as a result of steric hindrance of DNA strands, hydrogen bond-based DNA nanoassemblies often have loose internal structures, which are unfavorable for nanotherapeutic and bioimaging applications. Fifth, traditional DNA nanostructures can easily lose structural integrity during denaturation or at extremely low concentrations, which is unavoidable in an in vivo circulation system 30 .
Development of the protocol
To solve these problems, our group recently reported, for the first time, RCR-based programmable and multifunctional DNA NFs with a hierarchical inner structure 31, 32 . This kind of noncanonical DNA nanomaterial is demonstrated to have the advantages of exogenous nanomaterials, as well as DNA nanostructures, thus making it quite suitable for biomedical applications. NFs were generated from self-assembled compaction of a large amount of replicated DNA building blocks elongated through RCR 33 ( Fig. 1a) . A benefit of the RCR-based strategy is that only one template strand and one primer strand are needed in NF assembly, thus avoiding the large number of DNA strands that are typically used in constructing previously reported DNA nanostructures. In contrast to Watson-Crick base pairing-dependent DNA nanostructure construction, NFs are self-assembled through an anisotropic DNA liquid crystallization process, which circumvents the otherwise complicated sequence design needed to construct traditional DNA nanostructures for interstrand or intrastrand hybridization. Highly concentrated DNAs in NFs are thus densely and orderly packed so that a large number of functional DNA moieties such as therapeutics and bioimaging agents could be encapsulated. The size of NFs can be tuned from ~200 nm to a few micrometers by changing the RCR reaction time. In addition to their unique construction features including long and nonnicked DNA backbones, as well as dense DNA packaging, DNA NFs showed efficient resistibility toward severe environments including nuclease treatment, heat-or urea treatment-induced DNA denaturation and dilution to low concentrations. Resistance toward these factors is highly critical for many versatile applications in biomedicine.
More importantly, the liquid crystallization and dense packagingdriven NF formation is sequence-independent, which means in theory that any sequences that conform to the basic principle of RCR can be used to prepare NFs. Through rational design, numerous nucleic acid sequences with various reported functionalities can be simply integrated into NFs through polymerasemediated DNA elongation. For example, these can include functional moieties such as fluorescent agents for bioimaging (generated by modifying fluorophores on primers or using fluorophore-tethered deoxynucleotide triphosphates in RCR), aptamers [34] [35] [36] for use in selective cell targeting and drug-associated sequences for loading drugs [37] [38] [39] . Multifunctional NFs can therefore be implemented in versatile biomedical applications, such as early diagnosis and targeted cancer therapy (Fig. 1b) . Moreover, by simultaneously incorporating different fluorophores (fluorescein (FAM), cyanine 3 (Cy3) and 6-carboxyl-X-rhodamine (ROX)) into NFs via chemically modified deoxynucleotides (fluorescein-12-ddUTP, cyanine 3-dUTP and (6) ROX-12-ddUTP), multicolor NFs with a single excitation wavelength have also been proposed for multiplexed bioimaging with highly tunable emission wavelengths and spatial resolution 32 . Considering the programmability and flexibility of DNA NFs, we anticipate more potential applications for this emerging nanomaterial in the future through incorporation of nucleic acid sequences such as G-quadruplex 40 , i-motifs 41 or even DNAzymes 22, 42 .
In conclusion, RCR-based DNA NFs have shown exceptional promise and potential, as well as versatility, for applications in biomedicine. Specialists involved in cancer diagnosis and treatment will learn how the following protocol can be applied The linear DNA template was first hybridized with a primer and then ligated to form a circular template by T4 DNA ligase. Subsequently, phi29 DNA polymerase was used to perform RCR by polymerizing uncombined dNTP and dye-modified dUTP on the 3′-terminal end of the primer. RCR generated a large amount of elongated non-nicked concatemer DNA, and these DNAs then served as building blocks to self-assemble monodisperse, densely packed and hierarchical DNA NFs. NF sizes are tunable by changing the reaction time, with diameters ranging from ~200 nm to several micrometers. NF assembly does not rely on Watson-Crick base pairing between DNA building blocks, thus enabling tailored design of the template to carry multiple complements of functional nucleic acids. In this protocol, aptamers, drug-loading sites and dye molecules are integrated into NFs so that the prepared multifunctional NFs can act as smart nanotools for versatile biomedical applications such as targeted cancer cell recognition, bioimaging and targeted drug delivery. (b) Drug loading into NFs and targeted drug delivery. Doxorubicin (Dox) can be inserted into double-stranded 5′-GC-3′ or 5′-CG-3′ sequences by incubating it with NFs at room temperature. On the basis of the large number of generated drug-loading sites and internal hierarchical structures, drug payload capacity is extremely high when compared with other materials. The sgc8c aptamer incorporated can bind to PTK7-overexpressed cells, thereby endowing NFs with specific recognition toward target cancer cells. Dox will be released from NFs after intracellular uptake and cause selective apoptosis. The integrated dye molecules are used to give a fluorescence signal for intracellular imaging. to their studies, whether in biosciences or medical sciences. General readers from a broad spectrum of disciplines will also appreciate an introduction to this uniquely powerful tool for molecular medicine.
Experimental design
Incorporating cDNA aptamers into templates. Aptamers 35, 36, 43 are single-stranded oligonucleotides with a high affinity to special targets including metal ions, small organic molecules, proteins, viruses, cells and even tissues. Concatemeric ssDNA molecules containing multiple aptamers are expected to enhance the binding affinity of the resultant NFs to target cells through synergistic multivalent binding. This highlights the potential for future construction of NFs incorporated with therapeutic aptamers. Aptamers are generally 20-90 nt in length 34, [43] [44] [45] , which makes it possible to fully incorporate their complementary sequence into the NF template with no deletion. Aptamer sgc8c, which can specifically recognize protein tyrosine kinase 7 (PTK7) overexpressed on many cancer cells, was used as a model in this protocol 34, 46 . Sgc8c was demonstrated to selectively recognize target HeLa cells and CEM cells, but not nontarget Ramos cells. Table 1 gives the details of the sgc8c sequence and, for template design, its complementary sequence C-sgc8c. This method is based on RCR. As such, template design calls for cyclization by DNA ligase with the help of a primer. Therefore, we explain conceptually the construction of the template in a step-by-step manner using Figure 2 . First, the blank circular template shown in gray (Fig. 2a) is loaded with the C-aptamer targeting sequence (Fig. 2b) ; loading of additional sequences is discussed below.
Incorporating drug-loading sites into templates.
Previous studies have demonstrated that the anticancer drug doxorubicin (Dox) can be inserted into π-π stacking of double-stranded 5′-GC-3′ or 5′-CG-3′ sequences [37] [38] [39] . Following this principle, numerous designs have been shown in previous studies 47, 48 . Benefiting from the easy programmability of NFs, these drug-associated sequences could be easily incorporated into templates, such that the resultant RCR products could be decorated with a series of aptamers and drug-loading sites for Dox (Fig. 2c) . Oligonucleotide linkers such as poly-T or poly-A linkers are not needed between the aptamer portion and integrated drug-loading sequence, because they have no role in the construction and function of prepared DNA NFs. By incorporating drugloading sites into templates, polymerase-mediated replication endows the generated NFs with a large number of drug-associated sequences, ultimately amplifying the drug-carrying capacity of NFs with correspondingly improved therapeutic effect.
Incorporating bioimaging agent positions into templates. To perform intracellular imaging, the nucleotide adenosine (A) should be strategically spaced along the DNA template providing regular positions to attach dye-modified dUTPs to the replicated product (Fig. 2c) . Dye-modified dUTPs (fluorescein-12-ddUTP, cyanine 3-dUTP, (6) ROX-12-ddUTP or cyanine 5-dUTP in this protocol) can be recognized by many DNA polymerases, including phi29, and this enables their incorporation into NFs. When building the Förster resonance energy transfer (FRET) cascades that are required for implementation of a multifluorescent imaging platform 32 , dyes should be chosen on the basis of good spectral overlap as required by FRET-e.g., FAM, Cy3 and ROX. However, a comprehensive description of just one kind of fluorophore is used for the preparation of NFs in this protocol. Apart from adding the nucleotide adenosine for dye-modified dUTP attachment, it is also necessary to incorporate a sufficient number of thymine nucleobases into the template and to maintain the GC-rich domain in an intramolecular double-stranded form when positioning the nucleotide adenosine (Supplementary Fig. 1 ). During the design process, software such as NUPACK and Mfold can be used to simulate hybridization in order to simplify this procedure 26 . On the basis of the length of the aptamer and drug-associated sequences, the minimum number of nucleotides in the template should be more than 40 nt. Considering the efficiency of DNA synthesis and quality, as well as controllability, the maximum number of nucleotides is also suggested to be <120 nt.
Primer design. By following the same principle as RCR primer design, the primer should be designed such that it complements a domain of the template, which allows for subsequent elongation by DNA polymerase. The C-aptamer domain is regarded as the most suitable domain for hybridization with a primer because of its distinct and nonrepeating sequence compared with other domains, which thereby avoids nonspecific hybridization and ensures accurate intramolecular cyclization of the template (Fig. 2d) . At this stage, it is possible to add a fluorophore to the 3′-terminal oligonucleotide of the primer according to the users' own requirements (e.g., colocalization), although this is not discussed in the protocol. Thus far, we have designed a linear primer, as well as a circular template, with three functional domains: C-aptamer domain, drug-loading sequence and bioimaging agent positions. However, the template that is finally needed in the RCR reaction is a 5′-terminal-phosphorylated single-stranded DNA that can be intramolecularly cyclized by DNA ligase after hybridization with a primer, according to the principles of RCR. Therefore, when applying this design to the final template, it should be linearized in the middle of the C-aptamer domain because of its nonrepeating sequence (Fig. 2e) . The intramolecular hybridization of linear template can then be predicted by using a software program to determine the final structure and to eliminate the undesired secondary structures (Supplementary Fig. 1 ).
DNA preparation. Designed template and primer sequences ( Table 1) can be synthesized via a mature solid-state DNA synthesizer and purified with reversed-phase HPLC on a C-18 column. After desalting, UV-visible measurements can be performed with a UV-visible spectrometer for DNA quantification. The concentration of the DNA sequence is calculated through the Beer-Lambert law: A = εbc. It is worth mentioning that commercial DNAs are available for purchase, which will greatly simplify the protocol.
Self-assembly of monodisperse, size-tunable and densely packed multifunctional DNA NFs. During RCR-based NF preparation, the template and the primer are first annealed for complete and accurate hybridization, after which the template DNA is circularized by using T4 DNA ligase. This protocol uses only T4 DNA ligase; however, Escherichia coli DNA ligase is also effective at this stage. Ligation conditions should be adapted according to the manufacturer's instructions when using E. coli DNA ligase as an alternative. The hybridized primer is subsequently elongated by phi29 polymerase to generate periodic DNA with a myriad of aptamers, drug-loading moieties and bioimaging agents. By extending the reaction time, long and highly concentrated DNAs are produced ( Table 2 ). NFs will gradually assemble through DNA liquid crystallization, which is an anisotropic process for orderly alignment of highly concentrated polymers. The size of NFs is strongly dependent on RCR reaction time, and hence it can be tuned by optimizing the reaction time.
Characteristics of DNA NFs. NFs should be characterized after RCR to verify their quality. In our experiment, electrophoresis and confocal laser-scanning microscopy (CLSM) were used first to demonstrate the RCR result and to confirm the encapsulated fluorophore. Scanning electron microscopy (SEM) was then used to observe the size and surface morphology of NFs. Dynamic light scattering (DLS) was used to determine the hydrated radius of NFs. Transmission electron microscopy (TEM) and atomic force microscopy (AFM) were further used to characterize size and morphology. TEM images displayed hierarchical internal structures in NFs. Polarized light microscopy (PLM) was used to directly validate the liquid crystalline structures of NFs.
Stability of DNA NFs. As a result of the liquid crystallization and dense packaging-driven process, DNA condensation makes NFs more stable toward various environmental interferences, thus making them suitable for in vivo applications. Specifically, the exceptional stability of DNA NFs arises from their resistance to enzymolysis when incubated with 5 U/ml DNase I or 10% human serum, resistance to denaturation conditions when incubated at 170 °C or treated with 5 M urea and resistance to dissociation at low concentration (100× dilution). In our experiment, SEM imaging was used to verify the structural integrity of NFs after each treatment.
Aptamer-integrated DNA NFs for cell targeting. Aptamerintegrated DNA NFs were predicted to have similar or better recognition ability toward target cells compared with free aptamers, based on the multivalent effect of aptamers grafted onto the surface. In order to report a signal upon cancer cell binding, we integrated dye molecules into NFs through RCR. In this experiment, aptamer-integrated NFs were incubated with, and bound to, CEM and HeLa cancer cells, with Ramos cells as control. Such binding led to the endocytosis of NFs. Confocal microscopy and flow cytometry were then used to monitor the results, which showed satisfactory targeting performance of NFs toward target cells in comparison with control cells.
DNA NF-based drug delivery. The exceptional stability of DNA NFs makes them ideal candidates for drug delivery. In this protocol, dye molecules, preferably drug-associated sequences (e.g., double-stranded 5′-GC-3′ or 5′-CG-3′ sequences for anthracycline drugs in this protocol), and aptamers (sgc8c for CEM and HeLa cell lines) were incorporated into the template sequences to functionalize NFs as 'smart nanotherapists', which are able to specifically deliver anticancer drugs. Compared with other delivery systems, DNA NFs have obvious advantages such as high biocompatibility, flexible programmability, stability against physiological interference, as well as high drug-loading capacity and traceability. As the preparation of NFs is sequence-independent, all reported aptamer sequences can be incorporated into NFs by easily changing the anti-aptamer sequence within the template. 
h 2-4 µm
This could largely extend the scope of potential applications. NFs with a size of ~200 nm were used for intracellular experiments, essentially because nanomaterials of this size can be internalized by many cancer cells, according to previous reports 49, 50 . In order to prepare drug-loaded DNA NFs, Dox was incubated with the NFs dispersed in Dulbecco's PBS (DPBS). The loading amount could be calculated by measuring the absorption of free Dox in the supernatant on a UV-visible spectrometer. In our experiment, bioimaging of the intracellular behavior of NFs in target cells (CEM and HeLa) was performed with a Leica TCS SP5 confocal microscope in differential interference contrast (DIC) mode. An Ar laser was used for excitation of fluorescein and Dox, and a He-Ne laser was used for excitation of Cy3, ROX and Cy5. Nontarget Ramos cells were used as a control for each cell line; samples treated with no NFs were used as a control. Finally, the cytotoxicity of NFs, free drug (control) or drug-NF complexes was evaluated using the CellTiter 96 AQueous one solution cell proliferation assay.
Limitations DNA NFs are RCR-based self-assembled nanostructures that allow the integration of polymerase-recognized monomers (e.g., dNTP and dye-modified dUTP), which can partially limit the range of possible applications. In this protocol, only aptamers can be used as a cell-targeting moiety; other targeting functional groups such as antibodies and cell-receptor ligands are difficult to incorporate into the NF structure. However, considering the large number of proposed functional nucleic acids and the various targets of aptamers, we still think that the RCR-based DNA NFs show promise for versatile biomedical applications along with applications in other fields. DNA NFs cannot carry all kinds of drugs, but it is reported that the anthracycline class of drugs (e.g., Dox and daunomycin), which are widely used in cancer treatment, can intercalate into DNA and hence can be incorporated into NFs [37] [38] [39] . For other drugs or large molecules, microencapsulation may be an accessible pathway 51 .
In addition, because of dense DNA packaging, NFs showed relatively slow drug-release kinetics compared with other drug carriers such as mesoporous nanoparticles 4 , micelles 12 and hybridization-based DNA nanostructures 12, 17, 18, 22 . Hence, NFs are not favorable for situations in which quick drug release is necessary. In the fields of intracellular biosensing and analyte detection, NFs do not have advantages, in contrast to previously reported biosensing platforms such as graphene oxide nanosheets 52 , nanoparticles 53 , DNA dendrimers 22 and DNA tetrahedra 20 . This is because large quantities of DNA probes are packaged inside NFs, which means that they cannot function well toward target molecules.
It should also be noted that we have not yet found an adequate method for accurate quantification of NFs. NFs have diameters ranging from ~200 nm to a few micrometers, which are too small to be counted with a hemocytometer. Furthermore, once prepared, NFs cannot be completely dried for weighing in case of adhesion and agglomeration. To avoid this, we proposed a provisional method that measures and calculates the direct correlation between the concentration of NFs and maximum inserted Dox. Nevertheless, we still want to develop a reliable and direct method for NF quantification. Complete medium with 10% FBS and penicillin (100 U/ml)-streptomycin (100 µg/ml) To 500 ml of RPMI 1640 medium, add 50 ml of FBS (heat inactivated) and 5 ml of penicillin-streptomycin. Store it at −20 °C for at least 6 months or at 4 °C for up to 3 months. NaCl solution, 3 M To prepare 40 ml of 3 M NaCl solution, add 7.02 g of NaCl to 40 ml of double-distilled water. Store the solution at 4 °C for at least 6 months. Aqua regia Mix concentrated nitric acid and hydrochloric acid in a volume ratio of 1:3 in a 50-ml beaker. Aqua regia should be freshly made. 
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5|
Mix the tube by vortexing, and heat the mixture at 95 °C for 5 min. Cool the mixture slowly to room temperature over a period of 3 h.  crItIcal step Heating the DNA to 95 °C and subsequent gradual cooling to room temperature are important steps for complete hybridization of cDNAs. ? trouBlesHootInG 6| Add 2.5 µl of T4 DNA ligase (400,000 U/ml) to the annealed mixture, and mix it well with a pipette tip or by mildly vortexing it.  crItIcal step E. coli DNA ligase is also an effective substitute for T4 DNA ligase in this step. As noted in the discussion above, please follow the manufacturer's instructions for ligation conditions.
7|
Incubate the mixture at room temperature for 4 h.  pause poInt The ligated product can be stored at 4 °C for at least 1 month.
self-assembly of monodisperse, size-tunable and densely packed multifunctional Dna nFs • tIMInG ~1 d 8|
Prepare the following mixture in a 1.5-ml centrifuge tube on ice and mix it by pipetting.  crItIcal step Choose appropriate dye-modified dUTPs, according to your experiments. Fluorescein-12-ddUTP, cyanine 3-dUTP, (6) ROX-12-ddUTP and cyanine 5-dUTP are all available for NF preparation. Perform this step in an ice bath to maintain the activity of phi29 DNA polymerase.
9|
Seal the tube tightly with Parafilm to avoid the loss of solution by evaporation.
10|
Incubate the mixture at 30 °C for more than 6 h according to table 2.  crItIcal step By adjusting RCR reaction time, the size of NFs can be easily tuned. The relationship between RCR reaction time at 30 °C and NF size is shown in table 2. This protocol is adapted for the above-mentioned system. For other templates, a handy rule of thumb is that fewer base pairs correspond to a looser structure of produced NFs. NF sizes generated using a template with fewer base pairs become larger within the same reaction time. 11| Inactivate the phi29 DNA polymerase at 75 °C for 10 min to end the reaction.
12|
Centrifuge the product at 14,000g for 10 min at 20 °C.
13|
Remove the supernatant with a pipette and add 100 µl of DPBS.
14|
Resuspend NFs by pipetting the mixture up and down or by mildly vortexing it. 18| Load the samples in lanes and perform electrophoresis at 100 V for 40 min. 21| Pipette 10 µl of the diluted NF solution onto a microscope slide.
15|
22|
Use laser confocal fluorescence microscopy for NF imaging. Choose appropriate excitation and emission wavelengths according to the integrated fluorophore (for FAM, the maximum excitation wavelength is 496 nm and the maximum emission wavelength is 520 nm; for Cy3, the maximum excitation wavelength is 550 nm and the maximum emission wavelength is 564 nm; for ROX, the maximum excitation wavelength is 580 nm and the maximum emission wavelength is 630 nm; and for Cy5, the maximum excitation wavelength is 650 nm and the maximum emission wavelength is 662 nm). ! cautIon High-energy lasers can cause severe thermal burns. Sufficient protective equipment and careful operation are needed.  crItIcal step It is necessary to check the morphology and size of NFs using SEM during the growth process with a reaction time from 0.5 to 30 h to have a deeper understanding of the entire growth process. Figure 3 shows the referenced SEM results. After 0.5 h of reaction, irregular bulky structures formed, as shown in Figure 3a , and the bulky matrices then began to show some crystal-like structures on the surfaces at 1 h (Fig. 3b) . Subsequently, these crystal-like structures grew further to generate 'petal' structures at 2 h (Fig. 3c) . After 3 h, flower-like structures first appeared on the surface of matrices (Fig. 3d) , and the spherical NFs gradually cleaved off and split from each other to become monodisperse (Fig. 3e) .
The size of NFs kept growing over time, and diameters reached ~200 nm at 8 h (Fig. 3f) . After RCR for 10 h, the size of NFs reached 200-300 nm (Fig. 3g) , and after 15 h the SEM image shows an NF size of ~500 nm (Fig. 3h) . After a reaction time of 30 h, NFs with diameters of 2-4 µm were observed (Fig. 3i) , and, in all likelihood, they did not stop growing until the substrate had been exhausted. NF self-assembly is a time-dependent process, and by adjusting the RCR reaction time NFs with diameters ranging from ~200 nm to a few micrometers can be prepared according to the needs of each application. (ii) Add 10 µl of NF stock solution to the center of the mica sheet. The solution will spread over the whole surface.
(iii) Dry the sample naturally at room temperature.
(iv) Pipette 10 µl of ultrapure water onto the mica sheet and remove it after 5 s to wash away the salt crystals.  crItIcal step Be careful when you are adding or removing the solution with tips, to prevent damaging the mica surface. A rough mica surface may break the needle tip on the microcantilever, and it may reduce the imaging quality. (v) Image the NFs with an atomic force microscope using tapping mode in ambient air.
 crItIcal step AFM results can corroborate the size and monodispersity of NFs. For NFs with 10-15 h of reaction time, AFM results will show a diameter of ~150 nm with great monodispersity (supplementary Fig. 3d,e) . (e) plM imaging of nFs • tIMInG ~1 h (i) Add 5 µl of DPBS to 5 µl of NFs and mix it by mildly vortexing.
(ii) Pipette 10 µl of diluted NF solution on a microscope slide.
(iii) Use polarized light and a polarizing microscope for PLM.  crItIcal step When NFs are exposed between crossed polarizers, they display disc-shaped optical textures as a result of the birefringence of the liquid crystalline structure, which is an optical property of anisotropic materials (supplementary Fig. 3f,g ). The liquid crystalline structures of NFs can hence be directly illustrated.
examining resistance to nuclease degradation • tIMInG 1-2 d 24| Dilute DNase I to 50 U/ml with 1× DNase I buffer.  crItIcal step Perform this step in an ice bath.
25|
Add the following components to a 200-µl centrifuge tube. 
32|
Mix with a pipette tip.
33|
Seal the tube tightly with Parafilm.
34|
Incubate the mixture in a 37 °C water bath for 24 h.
35|
Use SEM to verify the structural integrity of NFs. Operations are defined in Step 23A.
examining thermal stability • tIMInG ~5 h 36| Pipette 10 µl of NF stock solution (from Step 15) on a silicon wafer.
37| Dry the samples at 70 °C for 2 h and subsequently incubate them at 170 °C in a high-temperature oven for 0.5 h. 
50|
Add the cell volume that yields the desired number of cells to a 15-ml centrifuge tube.
51|
Centrifuge the cells at 150g for 3 min at 4 °C.
52|
Remove the supernatant and add 3 ml of washing buffer. 64| Centrifuge 100 µl of NF stock solution in a 1.5-ml centrifuge tube at 14,000g and 20 °C for 15 min, and discard the supernatant.
65|
Resuspend the NFs with the prepared 100 µl of 2 mM Dox.
66|
Incubate the mixture at room temperature for 24 h.
67|
Centrifuge the mixture at 14,000g and 20 °C for 15 min. NFs will precipitate out, whereas free Dox remains in the supernatant. 
77|
Incubate 0, 0′, 1, 1′, 2 and 2′ in a cell culture incubator at 37 °C for 2 h.
78|
Centrifuge the tubes at 150g and 4 °C for 3 min and wash the cells twice with 1 ml of washing buffer.
79|
Resuspend the cells with 200 µl of DPBS using pipette tips, and transfer the cells into glass-bottomed microscope dishes individually. Label the dishes according to the tubes.
80| By using CLSM in DIC mode, perform bioimaging of intracellular behavior of NFs and Dox. Choose appropriate excitation and emission wavelengths according to the integrated fluorophore (see Step 22 for maximum excitation wavelength and maximum emission wavelength of different fluorophores; for Dox, maximum excitation wavelength is 480 nm and maximum emission wavelength is 580 nm).  crItIcal step All of the imaging parameters should be kept the same in order to compare the signal in each image. 87| Dilute every 20 µl of CellTiter reagent in 100 µl of fresh FBS-free medium. Add 100 µl of the diluted reagent to each well and incubate for 1-2 h in a cell culture incubator at 37 °C.
88|
Use a microplate reader to record the absorbance at 490 nm.
89|
Determine cell viability according to the manufacturer's description.
? trouBlesHootInG Troubleshooting advice can be found in table 3. deoxynuclease activity in human plasma. After treatment with 5 U/ml DNase I (a concentration considerably higher than that in human blood (<1 U/ml); supplementary Fig. 4a,b) or 10% human serum for 24 h, the NFs remain in flower structures, as displayed in SEM images (supplementary Fig. 4c ), thus demonstrating high stability toward enzymolysis. Most of the hydrogen bond-based DNA nanostructures will denature under severe conditions such as high temperature and high urea concentrations. However, in contrast to traditional hydrogen bonding, DNA NFs benefit from a unique stacking force, which can maintain structural integrity even at 170 °C (supplementary Fig. 4d ) or with 5 M urea treatment (supplementary Fig. 4e ). Resistance to dissociation at low concentration was also studied through diluting the NF reaction solution 100 times in water. No dissociation was observed in SEM imaging results (supplementary Fig. 4f ).
aptamer-integrated Dna nFs for cell targeting
Aptamer sgc8c can specifically recognize PTK7, which is overexpressed on many cancer cells. By incorporating sgc8c aptamer into NFs by RCR, DNA NFs are endowed with high affinity and selectivity toward the target cells, HeLa and CEM, compared with nontarget Ramos cells. A representative flow cytometry result is shown in supplementary Figure 5 . In this experiment, FAM-integrated NFs were used for cell targeting and signal reporting, and these NFs showed high recognition capability toward HeLa and CEM cells according to experimental result. No clear fluorescence signal shift was observed with nontarget Ramos cells. In conclusion, the conjugated aptamer preserves its binding affinity and specificity, making aptamer-integrated DNA NFs powerful nanotools for cell targeting.
Dna nF-based high-performance drug delivery
By incubating NFs with Dox in DPBS at room temperature for 24 h, Dox was loaded into the drug-loading sites of NFs. Drug-loaded NFs and free Dox can be separated through centrifugation at 14,000g and 20 °C for 5 min. After centrifugation, the supernatant is light-colored as a result of having lost part of Dox, whereas the NF concentrate turns dark red upon drug loading, as shown in supplementary Figure 6a . According to the described method, every 100 µl of prepared NF stock solution could load 66 nmol of Dox, and here we can calculate that the defined 1 U corresponds to an ~66-fold dilution of the original stock solution.
Bioimaging of intracellular behavior of NFs and Dox delivery by NFs is shown in Figure 4 . The green and red signals show that FAM-integrated NFs were taken up into the target cells and that drug molecules were released with high performance. In contrast, such fluorescence signals are difficult to visualize in control cells.
By treating target cells and nontarget cells with NFs, free Dox and NF-Dox complex in equivalent drug concentrations or NF concentrations, we further present the results of cell viabilities using an MTS assay. On the basis of the outstanding biocompatibility of DNA molecules, NFs showed no cytotoxicity toward either CEM or Ramos cells (supplementary Fig. 6b,c) . For target CEM and HeLa cells, the inhibition of Dox delivered by NFs on cell proliferation is similar to that of free Dox (supplementary Fig. 7a,b) . For nontarget Ramos cells, in contrast to free Dox, NF-Dox complexes induced distinctly less inhibition of cell proliferation (supplementary Fig. 7c) . These results distinctly demonstrated the selective cytotoxicity of NF-Dox complex toward target cells over nontarget cells, as well as the great potential of multifunctional NFs for targeted drug delivery and intracellular bioimaging. 
